29. Azain MJ. Role of fatty acids in adipocyte growth and development. J Anim Sci. 2004 Mar; 82 (3): 916–924.
30. Hutley LJ, Newell FM, Joyner JM, et al. Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation. Eur J Clin Invest. 2003 Jul; 33 (7): 574–581.
31. Alvheim AR, Malde MK, Osei-Hyiaman D, et al. Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity (Silver Spring). 2012 Oct; 20 (1): 1984–1994.
32. Massiera F, Saint-Marc P, Seydoux J, et al. Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J Lipid Res. 2003 Feb; 44 (2): 271–279.
33. Moon RJ, Harvey NC, Robinson SM, et al. Maternal plasma polyunsaturated fatty acid status in late pregnancy is associated with offspring body composition in childhood. J Clin Endocrinol Metab. 2013 Jan; 98 (1): 299–307.
34. Donahue SM, Rifas-Shiman SL, Gold DR, et al. Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohort. Am J Clin Nutr. 2011 Apr; 93 (4): 780–788.
35. Hill JO, Peters JC, Lin D, et al. Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord. 1993 Apr; 17 (4): 223–236.
36. Su W, Jones PJ. Dietary fatty acid composition influences energy accretion in rats. J Nutr. 1993 Dec; 123 (12): 2109–2114.
37. Baillie RA, Takada R, Nakamura M, et al. Coordinate induction of peroxisomal acyl-CoA oxidase and UCP-3 by dietary fish oil: a mechanism for decreased body fat deposition. Prostaglandins Leukot Essent Fatty Acids.1999 MayJun; 60 (5–6): 351–356.
38. Belzung F, Raclot T, Groscolas R. Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol. 1993 Jun; 264 (6 Pt 2): R1111–1118.
39. Kunesova M, Braunerova R, Hlavaty P, et al. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res. 2006; 55 (1): 63–72.
40. Там же.
41. Thorsdottir I, Tomasson H, Gunnarsdottir I, et al. Randomized trial of weightloss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond). 2007 Oct; 31 (1): 1560–1566.
42. Mater MK, Thelen AP, Pan DA, et al. Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription. J Biol Chem. 1999 Nov; 274 (46): 32725–32732.
43. Hulbert AJ, Else PL. Membranes as possible pacemakers of metabolism. J Theor Biol. 1999 Aug 7; 199 (3): 257–274.
44. Allport S. The queen of fats: why omega-3s were removed from the western diet and what we can do to replace them. Oakland (CA): University of California Press; 2006. 232 p.
45. Hulbert AJ, Else PL. Membranes as possible pacemakers of metabolism. J Theor Biol.1999 Aug 7; 199 (3): 257–274.
46. Там же.
47. Smith GI, Atherton P, Reeds DN, et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr. 2011 Feb; 93 (2): 402–412.
48. Smith GI, Julliand S, Reeds DN, et al. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr. 2015 Jul; 102 (1): 115–122.
49. Gingras AA, White PJ, Chouinard PY, et al. Long-chain omega-3 fatty acids regulate bovine whole-body protein metabolism by promoting muscle insulin signalling to the Akt-mTOR-S6K1 pathway and insulin sensitivity. J Physiol. 2007 Feb 15; 579 (Pt 1): 269–284.
50. Alexander JW, Saito H, Trocki O, et al. The importance of lipid type in the diet after burn injury. Ann Surg.1986 Jul; 204 (1): 1–8.
51. Berbert AA, Kondo CR, Almendra CL, et al. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition. 2005 Feb; 21 (2): 131–136.
52. Murphy RA, Mourtzakis M, Chu QS, et al. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer. 2011 Apr 15; 117 (8): 1775–1782.
53. Rodacki CL, Rodacki AL, Pereira G, et al. Fish-oil supplementation enhances the effects of strength training in elderly women. Am J Clin Nutr. 2012 Feb; 95 (2): 428–436.
54. Ryan AM, Reynolds JV, Healy L, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg. 2009 Mar; 249 (3): 355–363.
55. Whitehouse AS, Smith HJ, Drake JL, et al. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res. 2001 May; 61 (9): 3604–3609.
56. Smith GI, Julliand S, Reeds DN, et al. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr. 2015 Jul; 102(1): 115–122.
57. Jucker BM, Cline GW, Barucci N, et al. Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. Diabetes. 1999 Jan; 48 (1): 134–140.
58. Neschen S, Moore I, Regittnig W, et al. Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am J Physiol Endocrinol Metab. 2002 Feb; 282 (2): E395–401.
59. Vaughan RA, Garcia-Smith R, Bisoffi M, et al. Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells. Lipids Health Dis. 2012 Oct 30; 11: 142.
60. Rodacki CL, Rodacki AL, Pereira G, et al. Fish-oil supplementation enhances the effects of strength training in elderly women. Am J Clin Nutr. 2012 Feb; 95 (2): 428–436.
61. Peoples GE, McLennan PL, Howe PR, et al. Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol. 2008 Dec; 52 (6): 540–547.
1. Van Woudenbergh GJ, Kuijsten A, Van der Kallen CJ, et al. Comparison of fatty acid proportions in serum cholesteryl esters among people with different glucose tolerance status: the CoDAM study. Nutr Metab Cardiovasc Dis. 2012 Feb; 22 (2): 133–140.
2. Van Woudenbergh GJ, Kuijsten A, Van der Kallen CJ, et al. Comparison of fatty acid proportions in serum cholesteryl esters among people with different glucose tolerance status: the CoDAM study. Nutr Metab Cardiovasc Dis. 2012 Feb; 22 (2): 133–140.
3. Adapted from Eicosanoids [Интернет]. Wikipedia. Доступно по адресу https://upload.wikimedia.org/wikipedia/commons/5/58/EFA_to_Eicosanoids.svg.
4. Salomaa V, Ahola I, Tuomilehto J, et al. Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a populationbased study. Metabolism. 1990 Dec; 39 (1): 1285–1291.
5. Steffen LM, Vessby B, Jacobs DR, Jr., et al. Serum phospholipid and cholesteryl ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents. Int J Obes (Lond). 2008 Aug; 32 (8): 1297–1304.
6. Warensjo E, Rosell M, Hellenius ML, et al. Associations between estimated fatty acid desaturase activities in serum lipids and adipose tissue in humans: links to obesity and insulin resistance. Lipids Health Dis. 2009 Aug 27; 8: 37.
7. Pan DA, Lillioja S, Milner MR, et al. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest. 1995 Dec; 96 (6): 2802–2808.
8. Brenner RR. Hormonal modulation of delta6 and delta5 desaturases: case of diabetes. Prostaglandins Leukot Essent Fatty Acids. 2003 Feb; 68 (2): 151–162.
9. Emken EA, Adlof RO, Gulley RM. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta. 1994 Aug 4; 1213 (3): 277–288.
10. Там же.
11. Bezard J, Blond JP, Bernard A, et al. The metabolism and availability of essential fatty acids in animal and human tissues. Reprod Nutr Dev.1994; 34 (6): 539–568.
12. St-Onge MP, Bosarge A, Goree LL, et al. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. 2008 Oct; 27 (5): 547–552.
13. Van Wymelbeke V, Himaya A, Louis-Sylvestre J, et al. Influence of mediumchain and long-chain triacylglycerols on the control of food intake in men. Am J Clin Nutr. 1998 Aug; 68 (2): 226–234.
14. Mumme K, Stonehouse W. Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. J Acad Nutr Diet. 2015 Feb; 115 (2): 249–263.
15. Binnert C, Pachiaudi C, Beylot M, et al. Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols. Am J Clin Nutr. 1998 Apr; 67 (4): 595–601.
16. Assuncao ML, Ferreira HS, dos Santos AF, et al. Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesit y. Lipids. 2009 Jul; 44 (7): 593–601.
17. Liau KM, Lee YY, Chen CK, et al. An open-label pilot study to assess the efficacy and safety of virgin coconut oil in reducing visceral adiposity. ISRN Pharmacol. 2011; 2011: 949686.